Emcure Pharmaceuticals Limited
NSE: EMCURE
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Summary as recorded on Fri, 04 Sept, 2026.
Results
No scheduled results found for EMCURE.
Historical quarterly results aren't available in the current data feed.
Corporate Actions
No recent corporate actions for EMCURE.
Latest News · Emcure Pharmaceuticals Limited
Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.